Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商特朗奎斯治療股份有限公司filedCritical美商特朗奎斯治療股份有限公司
Publication of TW202415372ApublicationCriticalpatent/TW202415372A/en
208000037265diseases, disorders, signs and symptomsDiseases0.000titleabstract2
150000001875compoundsChemical class0.000abstract1
Abstract
The disclosure provides methods of delaying an aging-related change, increasing lifespan, and reducing risk of, delaying onset of, or treating an aging-related disease in a subject. The methods comprise administering to the subject an effective amount of a compound of Formula I.
TW112122072A2022-06-142023-06-13Treatment of aging-related changes and diseases
TW202415372A
(en)
method, ophthalmic formulation and kit for the treatment of modern to severe dry eyes; method for the treatment of chronic dry eye; and methods to reduce redness and inflammatory cytokine production by cells in the epithelium
Compositions and methods for treating, ameliorating, and/or preventing diseases or disorders caused by or associated with dnase1 and/or dnase1l3 deficiency